HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.

AbstractOBJECTIVE:
L1 cell adhesion molecule (L1CAM), as a member of the immunoglobulin superfamily, has recently been observed in a variety of human malignancies. However, no data of L1CAM are available for hepatocellular carcinoma (HCC). The aim of this study was to investigate the expression of L1CAM in HCC and determine its correlation with tumor progression and prognosis.
METHODS:
One-hundred and thirty HCC patients who had undergone curative liver resection were selected and immunohistochemistry, Western blotting, and quantitative real time polymerase chain reaction (Q-PCR) were performed to analyze L1CAM expression in the respective tumors.
RESULTS:
Immunohistochemistry, Western blotting, and Q-PCR consistently confirmed the overexpression of L1CAM in HCC tissues compared with their adjacent nonneoplastic tissues at both protein and gene level (both P <0.01). Additionally, the high expression of L1CAM was significantly associated with advanced tumor stage (P = 0.02) and advanced tumor grade (P = 0.03), respectively. Moreover, HCC patients with high L1CAM expression were significantly associated with lower 5-year overall survival (P <0.01) and lower 5-year disease-free survival (P <0.01), respectively. The Cox proportional hazards model further showed that L1CAM over-expression was an independent poor prognostic factor for both 5-year disease-free survival (P = 0.02) and 5-year overall survival (P = 0.008) in HCC.
CONCLUSION:
Our data suggest for the first time that L1CAM expression in HCC was significantly correlated with the advanced tumor progression and was an independent poor prognostic factor for both overall survival and disease-free survival in patients with HCC.
VIRTUAL SLIDES:
The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1970024872761542.
AuthorsXiaodong Guo, Lu Xiong, Lin Zou, Ting Sun, Jing Zhang, Hanwei Li, Ruiyun Peng, Jingmin Zhao
JournalDiagnostic pathology (Diagn Pathol) Vol. 7 Pg. 96 (Aug 13 2012) ISSN: 1746-1596 [Electronic] England
PMID22888955 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Neural Cell Adhesion Molecule L1
  • RNA, Messenger
Topics
  • Biomarkers, Tumor (analysis, genetics)
  • Blotting, Western
  • Carcinoma, Hepatocellular (chemistry, genetics, mortality, pathology, surgery)
  • Chi-Square Distribution
  • Disease Progression
  • Disease-Free Survival
  • Female
  • Gene Expression Regulation, Neoplastic
  • Hepatectomy
  • Humans
  • Immunohistochemistry
  • Kaplan-Meier Estimate
  • Liver Neoplasms (chemistry, genetics, mortality, pathology, surgery)
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neoplasm Grading
  • Neoplasm Staging
  • Neural Cell Adhesion Molecule L1 (analysis, genetics)
  • Prognosis
  • Proportional Hazards Models
  • RNA, Messenger (analysis)
  • Real-Time Polymerase Chain Reaction
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: